Order Article Reprints

Ludovini V, Bianconi F, Siggillino A, Vannucci J, Baglivo S, Berti V, Tofanetti FR, Reda MS, Bellezza G, Mandarano M, et al. High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients. Genes. 2021; 12(2):273. https://doi.org/10.3390/genes12020273

Ludovini, Vienna, Fortunato Bianconi, Annamaria Siggillino, Jacopo Vannucci, Sara Baglivo, Valeria Berti, Francesca Romana Tofanetti, Maria Sole Reda, Guido Bellezza, Martina Mandarano, and et al. 2021. "High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients" Genes 12, no. 2: 273. https://doi.org/10.3390/genes12020273

Ludovini, V., Bianconi, F., Siggillino, A., Vannucci, J., Baglivo, S., Berti, V., Tofanetti, F. R., Reda, M. S., Bellezza, G., Mandarano, M., Belladonna, M. L., Metro, G., Chiari, R., Sidoni, A., Puma, F., Minotti, V., & Roila, F. (2021). High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients. Genes, 12(2), 273. https://doi.org/10.3390/genes12020273